Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to BLADDER CANCER

Cancer Therapy Advisor

Novel Immunotherapy Plus BCG Effective for Unresponsive Bladder Cancer

Internal Medicine March 8th 2022

Journal of Clinical Oncology

TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients w. Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors

Internal Medicine May 12th 2021

FDA Approves Sacituzumab Govitecan for Advanced Urothelial Cancer

Internal Medicine April 20th 2021